Lipocine Correlations

LPCN Stock

USD 3.12 0.05 1.58%

The current 90-days correlation between Lipocine and Relay Therapeutics is -0.05 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lipocine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lipocine moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Lipocine Correlation With Market

Good diversification

The correlation between Lipocine and DJI is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Lipocine Stock

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.

Related Correlations Analysis

	INBX	PTGX	LRMR	VRDN	KYMR	ITOS	PCVX	RLAY
INBX		0.66	0.78	0.89	0.62	0.65	0.58	0.75	INBX
PTGX	0.66		0.74	0.82	0.91	0.83	0.62	0.67	PTGX
LRMR	0.78	0.74		0.86	0.82	0.68	0.64	0.92	LRMR
VRDN	0.89	0.82	0.86		0.8	0.79	0.71	0.81	VRDN
KYMR	0.62	0.91	0.82	0.8		0.85	0.66	0.81	KYMR
ITOS	0.65	0.83	0.68	0.79	0.85		0.57	0.69	ITOS
PCVX	0.58	0.62	0.64	0.71	0.66	0.57		0.69	PCVX
RLAY	0.75	0.67	0.92	0.81	0.81	0.69	0.69		RLAY
	INBX	PTGX	LRMR	VRDN	KYMR	ITOS	PCVX	RLAY

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Lipocine Stock performing well and Lipocine Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lipocine's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
INBX	3.07	1.12	0.31	3.06	2.67	(3.83)	7.99	(4.49)	15.98
PTGX	1.81	0.25	0.08	0.51	2.30	(1.81)	4.44	(2.84)	14.80
LRMR	5.07	0.74	0.14	0.45	5.55	(5.77)	10.88	(8.41)	40.34
VRDN	2.34	0.21	0.08	0.31	2.67	(2.50)	5.25	(3.76)	14.70
KYMR	3.18	0.92	0.26	0.87	2.76	(3.70)	6.98	(4.46)	48.99
ITOS	2.77	0.97	0.37	3.57	1.83	(4.15)	7.68	(3.81)	20.47
PCVX	3.04	0.05	0.03	0.16	3.65	(3.73)	6.93	(4.87)	21.28
RLAY	3.14	0.33	0.09	0.35	3.74	(3.25)	6.55	(6.35)	16.42

Lipocine Corporate Management

CPA CPA	Co Sec	Profile
Logan Morse	Marketing Sales	Profile
Nachiappan Chidambaram	Senior Development	Profile
M MD	Chief Director	Profile
Krista Fogarty	Principal Controller	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Lipocine Correlations

Lipocine Correlation With Market

Good diversification

Related Correlations Analysis

Risk-Adjusted Indicators

Lipocine Corporate Management

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY